Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating povetacicept in autoantibody-associated glomerular diseases is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. [EARLY_Phase 1]
Phase 1 study evaluating anti-CD19/BCMA universal CAR-T cell therapy RD06-05 in autoimmune diseases; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis [NA]
This entry describes a clinical trial evaluating per-protocol repeat kidney biopsy in incident lupus nephritis cases; the study is currently…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: The Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis
A clinical trial evaluating whether albumin/globulin ratio and platelet/albumin ratio serve as biomarkers in Lupus Nephritis; the study is n…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells [Phase 2]
A Phase 2 clinical trial evaluating allogeneic mesenchymal stem cells for lupus nephritis, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Daratumumab to Treat Active Lupus Nephritis [Phase 2]
A Phase 2 trial is investigating daratumumab for active lupus nephritis, and the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis [Phase 1, Phase 2]
Clinical trial update for MIL62 injection in lupus nephritis reporting tolerance, safety, pharmacokinetics, pharmacodynamics, and preliminar…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis and ANCA- Associated Vasculitis [Phase 4]
Phase 4 clinical trial evaluating the impact of SGLT-2 inhibitors on albuminuria in chronic kidney disease patients with lupus nephritis and…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
A recruiting clinical trial examining the relationships between serum uric acid, serum homocysteine, and interleukin-17 levels in patients w…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases [Phase 1]
Phase 1 clinical trial evaluating a BCMA/CD19 dual-targeted CAR-T cell therapy for autoimmune kidney diseases, currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease. [Phase 1, Phase 2]
MSC303 is being studied as a subcutaneous injection for lupus nephritis and ANCA-associated glomerulonephritis in Phase 1/Phase 2 trials, wi…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis [Phase 1]
A Phase 1 clinical trial evaluating NK010 or NK042 in combination with Rituximab for refractory systemic lupus erythematosus and refractory …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis
This clinical trial update reports on S100A8 levels in serum and urine as a potential biomarker for lupus nephritis. The study status is com…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Clinical trial RENAL AID from The Rogosin Institute is investigating novel analytes linked to autoimmune, inflammatory, and diabetic nephrop…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children [Phase 3]
This document updates on a Phase 3 clinical trial evaluating CAR-T cell therapy for refractory or recurrent lupus nephritis in children, whi…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
A clinical trial in Martinique is evaluating chlordecone impregnation for systemic lupus erythematosus with renal involvement; recruitment i…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE) [NA]
Clinical trial update indicates ongoing recruitment for Equecabtagene autoleucel (Eque-cel), a CAR-T therapy, for relapsed/refractory system…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Predictors of Bone Mineral Density in Lupus Nephritis Activity
Assiut University is conducting a clinical trial to identify predictors of bone mineral density in patients with lupus nephritis activity; t…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus
A clinical trial investigating the Systemic Immune Inflammatory Index in patients with Systemic Lupus Erythematosus and Lupus Nephritis is c…
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis [EARLY_Phase 1]
This update notes an early-phase Phase 1 trial of CD19/BCMA CAR-T cell therapy for refractory/relapsed lupus nephritis that is currently rec…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease [Phase 2]
This document reports a Phase 2 clinical trial evaluating an SGLT2 inhibitor in patients with lupus nephritis and chronic kidney disease. Th…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Urinary Congophilia as an Indicator of Activity of Lupus Nephritis
The study investigates urinary congophilia as a potential biomarker of lupus nephritis activity; the trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis [NA]
A clinical trial investigates how the combination of mycophenolate mofetil and cyclophosphamide affects lymphocyte subsets in patients with …
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: US Zamto-cel Autoimmune Diseases [Phase 1]
Miltenyi Biomedicine reports a Phase 1 trial of Zamto-cel for autoimmune diseases including lupus nephritis, systemic lupus erythematosus, s…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)
This update concerns the HOPE Cohort study of lupus nephritis in Guangzhou; the trial is currently recruiting and sponsored by the First Aff…